MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Stem cells. See also Human embryonic stem cells"

  • 2019 International Congress

    Disease-in-a-dish: drug discovery using patient-derived stem cells in Hereditary Spastic Paraplegia

    Y. Fan, G. Wali, R. Sutharsan, C. Sue, A. Mackay-Sim (Sydney, Australia)

    Objective: Identify a drug treatment for Hereditary Spastic Paraplegia (HSP) using patient-derived stem cell models Background: HSP is a neurological disorder characterised by axonal degeneration…
  • 2019 International Congress

    Texas Biorepository of Human Induced Pluripotent Stem Cells for Studying Parkinson’s Disease

    S. Wijemanne, H. Hong, G. Choudhury, J. Kim, J. Ramirez-Castaneda, A. Papanastassiou, M. Daadi (San Antonio, TX, USA)

    Objective: To develop a biorepository of human induced pluripotent stem cells for studying Parkinson’s disease(PD). Background: Genetically engineered stem cells called “induced pluripotent stem cells”…
  • 2019 International Congress

    Expression analysis of candidate genes in a cell model of affected and unaffected THAP1 mutation carriers and controls

    H. Baumann, M. Trilck-Winkler, M. Grosse, A. Münchau, V. Kostic, C. Klein, F. Kaiser, P. Seibler, K. Lohmann (Belgrade, Serbia)

    Objective: To evaluate the role of expressional changes in carriers of a THAP1 mutation in relation to penetrance of dystonia. Background: THAP1 encodes a transcription…
  • 2018 International Congress

    MicroRNA expression misregulation in iPSC-derived dopaminergic neurons from sporadic and LRRK2-associated Parkinson disease patients

    R. Fernández-Santiago, T. Botta-Orfila, X. Morató, C. Calatayud, R. Raquel, MJ. Martí, C. Gaig, A. Raya, A. Consiglio, E. Tolosa, M. Ezquerra (Barcelona, Spain)

    Objective: To investigate whether miRNA expression alterations occur in iPSC-derived DAn from sporadic PD (sPD) as well as monogenic LRRK2-associated PD patients. Background: MicroRNA (miRNA)…
  • 2018 International Congress

    Cell and animal models lacking RAB39B show biochemical and behavioural phenotypes that model aspects of Parkinson’s disease

    Y. Gao, G. Wilson, S. Stephenson, K. Bozaoglu, M. Dottori, P. Thomas, P. Lockhart (Melbourne, Australia)

    Objective: To determine the pathogenic mechanisms underlying RAB39B-mediated Parkinson’s disease (PD). Background: PD is a neurodegenerative disorder characterized by loss of dopaminergic neurons in the…
  • 2018 International Congress

    Transplantation therapy of human iPS cell-derived dopamine neural progenitor cells for Parkinson’s disease

    R. Nakamura, G. Oyama, T. Jo, K. Ishikawa, R. Nonaka, Y. Shimo, W. Akamatsu, N. Hattori (Tokyo, Japan)

    Objective: To examine the efficacy of midbrain dopaminergic progenitors derived from human iPS cells, as the cell source for Parkinson's disease model mouse, by analyzing…
  • 2018 International Congress

    Disease Modeling of DYT1 Using Patient Induced Pluripotent Stem Cells

    A. Dinasarapu, D. Sutcliffe, M. Zwick, H. Jinnah (Atlanta, GA, USA)

    Objective: To create a resource of induced pluripotent stem cells (iPSCs) as models for exploring mechanisms of pathogenesis in DYT1 dystonia. Background: DYT1 an autosomal…
  • 2018 International Congress

    Generation and in-depth characterization of induced pluripotent stem cell (iPSC) lines from 10 affected and unaffected carriers of THAP1 mutations

    H. Baumann, M. Trilck, M. Jahn, A. Münchau, V. Kostic, C. Klein, P. Seibler, K. Lohmann (Luebeck, Germany)

    Objective: To establish induced pluripotent stem cells (iPSCs) of affected and unaffected Mutation carriers to investigate disease mechanisms of THAP1 in dystonia. Background: Mutations in…
  • 2018 International Congress

    Disease Modeling of Lesch-Nyhan Disease Using Induced Pluripotent Stem Cells

    D. Sutcliffe, A. Dinasarapu, M. Zwick, H. Jinnah (Atlanta, GA, USA)

    Objective: To create a resource of induced pluripotent stem cells (iPSCs) as models for exploring mechanisms of pathogenesis in Lesch-Nyhan disease (LND). Background: LND is…
  • 2018 International Congress

    CRISPR/Cas9-based fluorescent tyrosine hydroxylase-reporter lines

    A. Rakovic, F. Vulinovic, C. Klein (Lübeck, Germany)

    Objective: To generate and characterize TH-GFP and -mCherry reporter iPSC lines. Background: Human induced pluripotent stem cells (iPSCs)-based dopaminergic neuronal (iDA) cultures emerged as a…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley